Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients

Biomarkers for predicting response to corticosteroid therapy for immune thrombocytopenic purpura

(2023) Naokazu Nakamura et al.   BRITISH JOURNAL OF HAEMATOLOGY

Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia

(2021) Yafei Yu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Anti-Glycoprotein Antibodies and Sequestration Pattern of Indium Labeled Platelets in Immune Thrombocytopenia

(2021) Sufia Nadjib Amini et al.   Blood Advances

Macrophage galactose lectin is critical for Kupffer cells to clear aged platelets

(2020) Carsten Deppermann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

(2020) Leah J McGrath et al.   Clinical Epidemiology

High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study

(2020) Jie Ma et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia

(2019) Hu Zhou et al.   INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION

First line treatment of adult patients with primary immune thrombocytopenia: a real-world study

(2019) Liang Wang et al.   PLATELETS

Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia

(2019) Richard Vollenberg et al.   HAEMATOLOGICA

Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis

(2019) Teeraya Puavilai et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune Thrombocytopenia

(2019) Nichola Cooper et al.   NEW ENGLAND JOURNAL OF MEDICINE

GPIbα is required for platelet-mediated hepatic thrombopoietin generation

(2018) Miao Xu et al.   BLOOD

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art

(2018) Leendert Porcelijn et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pathophysiology of immune thrombocytopenia

(2018) June Li et al.   CURRENT OPINION IN HEMATOLOGY

Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia

(2018) Mengxing Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

(2018) Jia Wang et al.   Biomed Research International

Response of first line treatment with corticosteroids in a population-based cohort of adults with primary immune thrombocytopenia

(2017) Henrik Frederiksen et al.   European Journal of Internal Medicine

Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells

(2017) Yun Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea

(2017) Ji Yun Lee et al.   THROMBOSIS RESEARCH

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)

(2017) Anne Zufferey et al.   Journal of Clinical Medicine

High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis

(2016) Siraj Mithoowani et al.   Lancet Haematology

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

(2015) Waleed Ghanima et al.   LANCET

Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia

(2015) June Li et al.   Nature Communications

Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study

(2014) J. Peng et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

(2013) S. Gudbrandsdottir et al.   BLOOD

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

(2012) V. L. Patel et al.   BLOOD

Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies

(2011) Qingshu Zeng et al.   AMERICAN JOURNAL OF HEMATOLOGY

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Recent progress in understanding the pathogenesis of immune thrombocytopenia

(2010) John W Semple et al.   CURRENT OPINION IN HEMATOLOGY

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

(2009) W. Marieke Schoonen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

(2008) R. Stasi et al.   BLOOD